Magenta Therapeutics, Inc.
MGTA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$37 | -$32 | -$30 | -$32 |
| Dep. & Amort. | $0 | $0 | $0 | -$0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $6 | $6 | $5 | $10 |
| Change in WC | $0 | $0 | $0 | $19 |
| Other Non-Cash | $0 | $2 | -$4 | -$16 |
| Operating Cash Flow | -$31 | -$24 | -$28 | -$19 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$280 | -$33 | -$67 | -$394 |
| Inv. Sales/Matur. | $79 | $60 | $82 | $52 |
| Other Inv. Act. | $0 | $0 | $0 | -$6 |
| Investing Cash Flow | -$201 | $26 | $15 | -$347 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $36 |
| Stock Repurch. | $0 | $0 | $0 | -$50 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $275 | $1 | $0 | $206 |
| Financing Cash Flow | $275 | $1 | $0 | $206 |
| Forex Effect | $0 | $0 | $0 | $12 |
| Net Chg. in Cash | $43 | $3 | -$13 | -$40 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $13 | $10 | $23 | $63 |
| End Cash | $56 | $13 | $10 | $23 |
| Free Cash Flow | -$31 | -$24 | -$28 | -$19 |